AZTR insider filings
Azitra, Inc. — 25 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-18. Screen AZTR transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AZTR between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Azitra, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | Salva Francisco D. — President and CEO, Director | Conversion (C): 4,064,050 · Conversion (C): 500 (derivative) | EDGAR |
| 2026-04-22 | 4 | Staskey Norm — Chief Financial Officer | Grant/award (A): 35,524 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Salva Francisco D. — President and CEO, Director | Grant/award (A): 220,879 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Whitfill Travis — Chief Operating Officer, Director | Grant/award (A): 64,300 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Salva Francisco D. — President and CEO, Director | Purchase (P): 500 (derivative) · Purchase (P): 4,064,050 (derivative) · Purchase (P): 4,064,050 (derivative) | EDGAR |
| 2025-12-22 | 4 | Whitfill Travis — Chief Operating Officer, Director | Grant/award (A): 23,724 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | Staskey Norm — Chief Financial Officer | Grant/award (A): 15,015 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | Schroer John R. — Director | Grant/award (A): 3,003 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | Salva Francisco D. — President and CEO, Director | Grant/award (A): 59,309 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | Ryan Barbara — Director | Grant/award (A): 3,003 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | Staskey Norm — Chief Financial Officer | Purchase (P): 47,600 @ $0.21 | EDGAR |
| 2024-02-15 | 4 | Whitfill Travis — Chief Operating Officer, Director | Purchase (P): 15,000 @ $0.30 | EDGAR |
| 2024-02-15 | 4 | Staskey Norm — Chief Financial Officer | Purchase (P): 3,300 @ $0.30 | EDGAR |
| 2024-02-15 | 4 | Salva Francisco D. — President and CEO, Director | Purchase (P): 333,300 @ $0.30 | EDGAR |
| 2023-10-03 | 4 | Whitfill Travis — Chief Operating Officer, Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | Staskey Norm — Chief Financial Officer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | Schroer John R. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | Ryan Barbara — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-07-24 | 4 | BAYER HEALTHCARE LLC — 10% owner Bayer US Holding LP — 10% owner Bayer World Investments B.V. — 10% owner BAYER AKTIENGESELLSCHAFT — 10% owner | Conversion (C): 1,307,401 · Conversion (C): 1,307,401 (derivative) @ $0 | EDGAR |
| 2023-06-29 | 4/A | McClary Andrew — Director | Conversion (C): 249,474 · Conversion (C): 42,437 · Conversion (C): 32,030 (derivative) @ $0 · Conversion (C) @ $0 | EDGAR |
| 2023-06-26 | 4 | McClary Andrew — Director | Conversion (C): 42,347 · Conversion (C): 16,975 · Conversion (C): 249,474 (derivative) @ $2.50 · Conversion (C) @ $2.50 | EDGAR |
| 2023-06-23 | 4 | Salva Francisco D. — President and CEO, Director | Grant/award (A): 5,000 @ $5 | EDGAR |
| 2023-06-23 | 4 | Whitfill Travis — Chief Operating Officer, Director | Grant/award (A): 250 @ $5 | EDGAR |
| 2023-06-23 | 4 | Fletcher Aaron G.L. — 10% owner BIOS Capital Management, LP — 10% owner BIOS Advisors GP, LLC — 10% owner BIOS Fund III, LP — 10% owner BIOS Fund III QP, LP — 10% owner BIOS Fund III NT, LP — 10% owner BIOS Equity Partners III, LP — 10% owner BIOS Azitra Co-Invest I, LP — 10% owner | Sale (S): 77,953 · Purchase (P): 197,701 · Purchase (P): 69,880 @ $5 · Conversion (C): 137,186 · Sale (S): 509,141 · Purchase (P): 1,291,258 · +27 more | EDGAR |
| 2023-06-23 | 4 | Kreis Leslie W. — 10% owner Cavu Advisors, LLC — 10% owner Cavu Management, LP — 10% owner BIOS Fund I, LP — 10% owner BIOS Fund I QP, LP — 10% owner Bios Equity Partners, LP — 10% owner BIOS Fund II, LP — 10% owner BIOS Fund II NT, LP — 10% owner BIOS Fund II QP, LP — 10% owner Bios Equity Partners II, LP — 10% owner | Sale (S): 77,953 · Purchase (P): 197,701 · Purchase (P): 69,880 @ $5 · Conversion (C): 137,186 · Sale (S): 509,141 · Purchase (P): 1,291,258 · +27 more | EDGAR |
Recent 8-K events — Azitra, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AZTR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →